Avanos (AVNS) Medical announced the appointment of David Pacitti as its new CEO, effective April 14. Pacitti joins Avanos with a distinguished career in the healthcare sector, most recently serving as president of Siemens Medical Solutions USA and Head of the Americas, Siemens Healthineers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVNS:
- Avanos Medical: Hold Rating Amidst Transformational Challenges and Market Uncertainties
- Avanos Medical’s Earnings Call: Mixed Sentiments and 2025 Outlook
- Avanos Medical Reports 2024 Financial Results
- Avanos Medical: Balancing Strong Q4 Performance with Strategic Challenges – Hold Rating Maintained
- Avanos price target lowered to $17 from $20 at Stifel